Mitigation of endemic GI-tract pathogen-mediated inflammation through development of multimodal treatment regimen and its impact on SIV acquisition in rhesus macaques.

Saved in:
Bibliographic Details
Title: Mitigation of endemic GI-tract pathogen-mediated inflammation through development of multimodal treatment regimen and its impact on SIV acquisition in rhesus macaques.
Authors: Bochart RM; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America., Busman-Sahay K; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America., Bondoc S; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America., Morrow DW; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America., Ortiz AM; Barrier Immunity Section, Lab of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United State of America., Fennessey CM; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Fischer MB; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America., Shiel O; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America., Swanson T; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America., Shriver-Munsch CM; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America., Crank HB; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America., Armantrout KM; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America., Barber-Axthelm AM; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America., Langner C; Barrier Immunity Section, Lab of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United State of America., Moats CR; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America., Labriola CS; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America., MacAllister R; Division of Comparative Medicine, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America., Axthelm MK; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America., Brenchley JM; Barrier Immunity Section, Lab of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United State of America., Keele BF; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Estes JD; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America., Hansen SG; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America., Smedley JV; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Source: PLoS pathogens [PLoS Pathog] 2021 May 10; Vol. 17 (5), pp. e1009565. Date of Electronic Publication: 2021 May 10 (Print Publication: 2021).
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33970966
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Mitigation of endemic GI-tract pathogen-mediated inflammation through development of multimodal treatment regimen and its impact on SIV acquisition in rhesus macaques.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bochart+RM%22">Bochart RM</searchLink>; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Busman-Sahay+K%22">Busman-Sahay K</searchLink>; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Bondoc+S%22">Bondoc S</searchLink>; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Morrow+DW%22">Morrow DW</searchLink>; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Ortiz+AM%22">Ortiz AM</searchLink>; Barrier Immunity Section, Lab of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United State of America.<br /><searchLink fieldCode="AU" term="%22Fennessey+CM%22">Fennessey CM</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Fischer+MB%22">Fischer MB</searchLink>; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Shiel+O%22">Shiel O</searchLink>; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Swanson+T%22">Swanson T</searchLink>; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Shriver-Munsch+CM%22">Shriver-Munsch CM</searchLink>; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Crank+HB%22">Crank HB</searchLink>; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Armantrout+KM%22">Armantrout KM</searchLink>; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Barber-Axthelm+AM%22">Barber-Axthelm AM</searchLink>; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Langner+C%22">Langner C</searchLink>; Barrier Immunity Section, Lab of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United State of America.<br /><searchLink fieldCode="AU" term="%22Moats+CR%22">Moats CR</searchLink>; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Labriola+CS%22">Labriola CS</searchLink>; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22MacAllister+R%22">MacAllister R</searchLink>; Division of Comparative Medicine, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Axthelm+MK%22">Axthelm MK</searchLink>; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Brenchley+JM%22">Brenchley JM</searchLink>; Barrier Immunity Section, Lab of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United State of America.<br /><searchLink fieldCode="AU" term="%22Keele+BF%22">Keele BF</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Estes+JD%22">Estes JD</searchLink>; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Hansen+SG%22">Hansen SG</searchLink>; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Smedley+JV%22">Smedley JV</searchLink>; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101238921%22">PLoS pathogens</searchLink> [PLoS Pathog] 2021 May 10; Vol. 17 (5), pp. e1009565. <i>Date of Electronic Publication: </i>2021 May 10 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101238921 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1553-7374 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215537366%22">15537366 </searchLink><i>NLM ISO Abbreviation: </i>PLoS Pathog <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33970966
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.ppat.1009565
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e1009565
    Titles:
      – TitleFull: Mitigation of endemic GI-tract pathogen-mediated inflammation through development of multimodal treatment regimen and its impact on SIV acquisition in rhesus macaques.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bochart RM
      – PersonEntity:
          Name:
            NameFull: Busman-Sahay K
      – PersonEntity:
          Name:
            NameFull: Bondoc S
      – PersonEntity:
          Name:
            NameFull: Morrow DW
      – PersonEntity:
          Name:
            NameFull: Ortiz AM
      – PersonEntity:
          Name:
            NameFull: Fennessey CM
      – PersonEntity:
          Name:
            NameFull: Fischer MB
      – PersonEntity:
          Name:
            NameFull: Shiel O
      – PersonEntity:
          Name:
            NameFull: Swanson T
      – PersonEntity:
          Name:
            NameFull: Shriver-Munsch CM
      – PersonEntity:
          Name:
            NameFull: Crank HB
      – PersonEntity:
          Name:
            NameFull: Armantrout KM
      – PersonEntity:
          Name:
            NameFull: Barber-Axthelm AM
      – PersonEntity:
          Name:
            NameFull: Langner C
      – PersonEntity:
          Name:
            NameFull: Moats CR
      – PersonEntity:
          Name:
            NameFull: Labriola CS
      – PersonEntity:
          Name:
            NameFull: MacAllister R
      – PersonEntity:
          Name:
            NameFull: Axthelm MK
      – PersonEntity:
          Name:
            NameFull: Brenchley JM
      – PersonEntity:
          Name:
            NameFull: Keele BF
      – PersonEntity:
          Name:
            NameFull: Estes JD
      – PersonEntity:
          Name:
            NameFull: Hansen SG
      – PersonEntity:
          Name:
            NameFull: Smedley JV
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 05
              Text: 2021 May 10
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1553-7374
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: PLoS pathogens
              Type: main
ResultId 1